UNIV DEGLI STUDI URBINO has a total of 13 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Italy, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are ARTESIAN THERAPEUTICS INC, PHARMACOPEIA DRUG DISCOVERY and BACON EDWARD R.
# | Country | Total Patents | |
---|---|---|---|
#1 | Italy | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Magnani Mauro | 8 |
#2 | Filippone Paolino | 6 |
#3 | Fiorucci Chiara | 5 |
#4 | Paiardini Mirko | 5 |
#5 | Brandi Giorgio | 5 |
#6 | Fanelli Mirco | 3 |
#7 | Fusi Vieri | 3 |
#8 | Ruzzo Annamaria | 3 |
#9 | Graziano Francesco | 3 |
#10 | Attanasi Orazio Antonio | 1 |
Publication | Filing date | Title |
---|---|---|
WO2010061282A1 | Derivatives of [(3-hydroxy-4 pyron-2-yl)methyl]-amine and use thereof as anti-neoplastic drugs | |
AU2002358976A1 | Germ line mutation in the promoter of e-caderine and diagnostic method for finding a greater susceptibility to gastric carcinoma | |
EP1395595A1 | Tetramerous derivative of indole-3-carbinol with anti-carcinogenic activity and method of synthesis of said derivative |